Euroopa Liit - inglise - EMA (European Medicines Agency)

takeda manufacturing austria ag - human normal immunoglobulin (ivig) - purpura, thrombocytopenic, idiopathic; bone marrow transplantation; immunologic deficiency syndromes; guillain-barre syndrome; mucocutaneous lymph node syndrome - immune sera and immunoglobulins, - replacement therapy in adults, and children and adolescents (0-18 years) in:primary immunodeficiency syndromes with impaired antibody production;hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed;hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who have failed to respond to pneumococcal immunisation;hypogammaglobulinaemia in patients after allogeneic haematopoietic-stem-cell transplantation (hsct);congenital aids and recurrent bacterial infections.immunomodulation in adults, and children and adolescents (0-18 years) in:primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;guillain barré syndrome;kawasaki disease;multifocal motor neuropathy (mmn).

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - human papillomavirus (hpv) 11 l1 protein 40ug;  ; human papillomavirus (hpv) 16 l1 protein 60ug;  ; human papillomavirus (hpv) 18 l1 protein 40ug;  ; human papillomavirus (hpv) 31 l1 protein 20ug;  ; human papillomavirus (hpv) 33 l1 protein 20ug;  ; human papillomavirus (hpv) 45 l1 protein 20ug;  ; human papillomavirus (hpv) 52 l1 protein 20ug;  ; human papillomavirus (hpv) 58 l1 protein 20ug;  ; human papillomavirus (hpv) 6 l1 protein 30ug;   - suspension for injection - 0.5 ml - active: human papillomavirus (hpv) 11 l1 protein 40ug   human papillomavirus (hpv) 16 l1 protein 60ug   human papillomavirus (hpv) 18 l1 protein 40ug   human papillomavirus (hpv) 31 l1 protein 20ug   human papillomavirus (hpv) 33 l1 protein 20ug   human papillomavirus (hpv) 45 l1 protein 20ug   human papillomavirus (hpv) 52 l1 protein 20ug   human papillomavirus (hpv) 58 l1 protein 20ug   human papillomavirus (hpv) 6 l1 protein 30ug   excipient: aluminium as amorphous aluminium hydroxyphosphate sulfate adjuvant histidine polysorbate 80 sodium borate sodium chloride water for injection - gardasil 9 is indicated in females aged 9 through 45 years for the prevention of cervical, vulvar, vaginal and anal cancer, precancerous or dysplastic lesions, genital warts, and infection caused by human papillomavirus (hpv) types 6, 11, 16, 18, 31, 33, 45, 52 and 58 (which are included in the vaccine). gardasil 9 is indicated in males 9 through 45 years of age for the prevention of anal cancer, precancerous or dysplastic lesions, external genital lesions and infection caused by hpv types 6, 11, 16, 18, 31, 33, 45, 52 and 58 (which are included in the vaccine).

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

gnp australia pty ltd - 60600 - joint lubrication gel - lubricating gel for topical application for arthritic joints to assist joint movement, improve joint function and reduce joint pain in rheumatoid arthritis, osteoarthritis, psoriatic arthritis and general painful joint movement. this lubricating gel will soothe stiff, sore and aching joints and can be used as often and as much as required.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

nature's care manufacture pty limited - glucosamine hydrochloride, quantity: 750 mg; shark sodium chondroitin sulfate, quantity: 250 mg - capsule, hard - excipient ingredients: magnesium stearate; colloidal anhydrous silica; purified water; gelatin; sodium lauryl sulfate - maintain/support connective tissue health ; decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; helps maintain/supports healthy joint cartilage growth/development/production ; helps enhance/promote healthy joint function ; maintain/support joint health ; decrease/reduce/relieve mild joint inflammation/swelling ; maintain/support joint mobility/flexibility ; decrease/reduce/relieve mild joint stiffness

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 44742 - prosthetic joint implantation kit - orthopedic instrumentation needed to implant knee, hip, shoulder, wrist, finger, toe, elbow, arthroscopic prosthetics

Malta - inglise - Medicines Authority

takeda manufacturing austria ag industriestrasse 67, a-1221, vienna, austria - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 250 iu von willebrand factor, human 190 iu - antihemorrhagics

Malta - inglise - Medicines Authority

takeda manufacturing austria ag industriestrasse 67, a-1221, vienna, austria - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 500 iu von willebrand factor, human 375 iu - antihemorrhagics

Malta - inglise - Medicines Authority

takeda manufacturing austria ag industriestrasse 67, a-1221, vienna, austria - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 1000 iu von willebrand factor, human 750 iu - antihemorrhagics

Euroopa Liit - inglise - EMA (European Medicines Agency)

takeda manufacturing austria ag - c1 inhibitor (human) - angioedemas, hereditary - c1-inhibitor, plasma derived, drugs used in hereditary angioedema - treatment and pre-procedure prevention of angioedema attacks in adults, adolescents and children (2 years old and above) with hereditary angioedema (hae).routine prevention of angioedema attacks in adults, adolescents and children (6 years old and above) with severe and recurrent attacks of hereditary angioedema (hae), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.

Euroopa Liit - inglise - EMA (European Medicines Agency)

co.don gmbh - spheroids of human autologous matrix-associated chondrocytes - cartilage diseases - other drugs for disorders of the musculo-skeletal system - repair of symptomatic articular cartilage defects of the femoral condyle and the patella of the knee (international cartilage repair society [icrs] grade iii or iv) with defect sizes up to 10 cm2 in adults.,